Docket Number:12A-1070917
Inventor:Patrick Ching-Ho Hsieh, David Lundy
IP Status:USP
Abstract:
Treating brain diseases is extremely challenging due to the presence of the Blood-Brain Barrier (BBB), which prevents 98% of clinically prescribed drugs from entering the brain. As a result, the median survival rate for a patient with glioblastoma multiforme, a severe form of brain cancer, is less than 1.5 years after diagnosis. Dr. Hsieh’s team discovered a new method to temporarily weaken the BBB, thereby allowing selected chemotherapy drugs to enter the parts of the brain where the tumor needs to be treated. In experiments with mice, this discovery was shown to have helped delay tumor progression and extend survival rates by more than 30%.
Fields of Application:
Brain tumors and other brain diseases.
Advantages when compared to the existing technologies:
This technique is using a drug pretreatment to induce a temporary window of enhanced BBB permeability. Dr. Hsieh’s team have found no evidence of systemic toxicity, and the technique was replicated in pigs, demonstrating that this technique could be scaled up and potentially be translated to the clinic, thus allowing the use of nanocarrier-based therapies for brain disorders.
Contact Person:Chia-Yu Wu / 886-2-2787-2602 / cyw@gate.sinica.edu.tw
